SITO Mobile and Blue Bite Partner to Create Powerful

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SITO Mobile and Blue Bite Partner to Create Powerful Location-Based Targeting Tools with Real Time In-store Attribution

JERSEY CITY, N.J., Sept. 26, 2016 (GLOBE NEWSWIRE) -- Today, SITO Mobile Ltd. (NASDAQ: SITO ), a leading mobile engagement platform, announces a data and product development partnership with Blue Bite, a top cloud-based IoT platform company.

SITO Mobile’s Marketing Platform provides advertisers access to more than 98% of U.S. mobile consumers via 200,000 of the world’s most popular apps to present consumers with digital display and video ads.  SITO Mobile’s owned-and-operated platform processes more than 4.5 trillion mobile data points monthly through its machine-learning algorithms, continuously improving SITO Mobile’s location-based audience targeting and real time delivery optimization – and delivering superior advertising results. The Marketing Platform also integrates SITO Mobile’s proprietary campaign measurement and attribution service, Real Time Verified Walk-In (VWI).  SITO will add data supplied by Blue Bite to SITO’s Data Management Platform (DMP), creating new mobile advertising opportunities to connect brands and customers at scale.

Blue Bite’s physical-to-digital IoT Platform now powers a network of over 280,000 smart objects, including products, retail spaces, and out-of-home media placements. The platform integrates with eight different mobile technologies including NFC enabled touchpoints, Bluetooth beacons and WiFi access points. The platform analyzes data from a multitude of sources in real-time, and translates those data points into usable insight that drives contextually relevant mobile experiences for consumers.

SITO and Blue Bite are partnering to combine Blue Bite’s hyper-local physical sensor level data with SITO Mobile’s rich geo-based mobile data to enhance SITO’s attribution technology (VWI) and to improve location-based targeting for both SITO and Blue Bite campaigns. This will provide SITO with more precise geographic attribution in areas with many points-of-interest under one roof (for example: shopping malls) and also provide dwell time at points-of-interest. Additionally, the partnership will bring greater depth to Blue Bite’s audience data, enabling its platform to deliver more relevant content and digital experiences to consumers.

The partnership will also allow content including video to be delivered based on a consumer’s proximity to specific locations and will allow brands to extend their mobile message from out-of-home and/or retailer touch points to mobile devices. With SITO’s coverage of 98% of households and Blue Bite’s proximity-based targeting, advertisers will be able to reach the right audiences at scale, at the right time, while bolstering the data assets of both companies.

In today’s mobile digital economy, consumers are able to retrieve information faster and more efficiently than ever before. They can now be targeted immediately while they are in close proximity to a particular product, further enhancing the value of the mobile experience and delivering content even more tailored to each individual user. As a result, consumers will be able to receive exclusive local deals, rewards, and news from wearables, bus stops and other connected objects. 

“We enthusiastically welcome Blue Bite to SITO’s growing ecosystem of data and product partners,” said Jerry Hug, CEO of SITO Mobile.  “We are eager to leverage our complementary technology and touchpoints to enrich our combined data assets and create an even more powerful value proposition for marketers. We look forward to taking advantage of the various opportunities that emerge by combining Blue Bite’s network with SITO’s far reaching mobile audiences and data set."

“We're excited by the opportunity to combine these two technologies - both for its immediate value but also for their future possibilities,” said Jon Lowen, SITO Mobile’s EVP of Operations and Product Development. “The ability to leverage micro-local data from products and retailers provides SITO Mobile with a new level of geographic precision that enhances our attribution and targeting capabilities— further setting us apart from other location based advertising options.”

Mikhail Damiani, CEO & Co-founder of Blue Bite, shared his sentiments, “Partnering with SITO Mobile is yet another step in the right direction in our quest to improve the Blue Bite platform. This symbiotic relationship will allow us to strengthen our audience data, in-turn empowering brands to deliver the best mobile experience to their customers.  We are excited about working together to improve the value of the content and messaging that both engages and retains mobile users.”

About SITO Mobile Ltd.

SITO Mobile provides a mobile engagement platform that enables brands to increase awareness, loyalty, and ultimately sales. For more information, visit  www.sitomobile.com .

About Blue Bite

Blue Bite is a leading IoT mobile solutions provider focused on adding digital experiences to objects in the physical world. With hundreds of thousands of deployments in outdoor media, retail, consumer products and apparel, Blue Bite leverages a mix of mobile technologies to empower conversations between consumers and the objects and media around them. The Company has developed a revolutionary platform that manages dynamic content and supports seamless interactivity, data flow and reporting through eight unique technologies. For more information, please visit  www.bluebite.com  and follow the latest updates and developments on Facebook and Twitter.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, sales growth, our reliance on brand owners and wireless carriers, the possible need for additional capital as well as other risks identified in our filings with the SEC. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

RELATED LINKS http://www.sitomobile.com

Contact: Investor Relations: Joseph Wilkinson SVP Investor Relations Joseph.Wilkinson@sitomobile.com Media Relations: Alexandra Levy Silicon Alley Media alex@siliconalley-media.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Market News: Nasdaq Dips as Applied Materials Shines

Updated Category News Views 191

Stock Market Declines on Nasdaq Today, U.S. stocks faced challenges with the Nasdaq Composite dropping significantly. The market opened lower with declines across major indices, signaling a cautious trading atmosphere. Market Overview As the day progressed, the Dow Jones Industrial Average fell by 1.21% to 46,882.86, while the NASDAQ retreated by 1.51%, settling at...

Continue Reading
Fastly Eyewitness: A Look at Recent Stock Performance

Updated Category News Views 205

Fastly's Impressive Stock Surge Fastly stock has recently shown remarkable movement, trading at near recent highs, indicating strong investor confidence in the company. The notable increase has left many wondering how long this momentum can be sustained. AI Transformation Sparks Interest Shifting Perspectives in Technology The recent ascent of Fastly's stock is largely...

Continue Reading
Exploring the Transformation of Social Media Management Market

Updated Category News Views 139

Understanding the Evolution of the Social Media Management Market The social media management market is experiencing remarkable growth. From a value of $17.5 billion in 2022, projections indicate it may reach $51.8 billion by 2027. This surge represents a compound annual growth rate (CAGR) of 24.2%. Companies worldwide are adapting to the increasing reliance on social...

Continue Reading
WestBond Enterprises Posts Year-End Financial Results and Outlook

Updated Category News Views 166

WestBond Enterprises Financial Overview WestBond Enterprises Corporation (TSX-V: WBE), a notable player in the manufacturing sector, has reported a financial loss of $52,380 for the year ending in March, reflecting a notable decrease from the previous year's loss of $210,683. Despite the loss, the company experienced a 4.9% increase in sales, which totaled $9,673,002,...

Continue Reading
Investors of Ultra Clean Urged to Act Amidst Stock Decline

Updated Category News Views 239

Investigation by Faruqi & Faruqi for Ultra Clean Investors Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors who have experienced losses exceeding $50,000 in Ultra Clean Holdings, Inc. (NASDAQ: UCTT). The firm aims to discuss potential legal options available to these investors following troubling financial disclosures from Ultra...

Continue Reading